# Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne Vulgaris

> **NCT00160394** · PHASE4 · COMPLETED · sponsor: **Stiefel, a GSK Company** · enrollment: 130 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Duac® Gel / Differin® Gel

## Key facts

- **NCT ID:** NCT00160394
- **Lead sponsor:** Stiefel, a GSK Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2005-08
- **Final completion:** 2005-08
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2017-05-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00160394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00160394, "Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne Vulgaris". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00160394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*